Tissue Regenix Group Banner Image

Tissue Regenix Group

  • Ticker TRX
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Tissue Regenix Group Logo Image
  • 51-200 Employees
  • Based in Garforth, England
Tissue Regenix is a leading medical devices company in the field of regenerative medicine. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds, UK. The company's patented decellularisation ('dCELL®'​) technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient'sMore body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care.
4.8 / 5.0 (96)

Tissue Regenix Group reports have an aggregate usefulness score of 4.8 based on 96 reviews.

Tissue Regenix Group

Most Recent Annual Report

Tissue Regenix Group
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Tissue Regenix Group Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!